SAVE THE DATE
JW Marriott Orlando Bonnet Creek Resort & Spa
Come join your colleagues from around the world to network and discuss challenges and opportunities for the global generics and biosimilars industries. For the first time since 2014, IGBA’s Annual Conference is being held in the United States, in conjunction with AAM’s Access! 2023 Annual Meeting. This event will offer a unique opportunity to hear from leading global stakeholders, industry leaders and other experts offering their views and analysis of the most pressing policy questions influencing patient access to generic and biosimilar medicines in countries around the world.
Registration opening July 2022.
Two Conferences - One Event
And, if you’re interested in learning more about the key issues affecting patient access to generics and biosimilars in the United States, make sure to arrive early to attend AAM’s Access! 2023 Annual Meeting, which will take place February 13-15 at the same hotel.
There will be professional networking opportunities and social events. Whether you’re looking to advance your career or learn informally from an industry leader, you will find no better time or place. Meet up with old colleagues or potential collaborators.
Raise your company profile by participating in this prestigious event. For more information regarding sponsorship levels and benefits contact Aquera Agee at Aquera.Agee@accessiblemeds.org.
IGBA’s 25th Annual Conference offers a professional business environment in which industry vendors can meet global generics and biosimilars industries executives. Showcase your company and share your solution while building your brand, connecting with new prospects, meeting with current clients and leaving with solid connections.
For questions regarding exhibiting at Access! 2023, please contact Aquera Agee at email@example.com.
Attendee Duty of Care
AAM and IGBA recognize ensuring the safety of all of those attending these meetings is a top priority. Our organizations are committed to following CDC, government and Marriott Covid-19 health and safety guidelines for in-person events.